Caricamento...
Beyond Glucagon-like Peptide-1: Is G-Protein Coupled Receptor Polypharmacology the Path Forward to Treating Metabolic Diseases?
[Image: see text] The glucagon-like peptide-1 receptor (GLP-1R) is a class B G-protein coupled receptor (GPCR) that has proven to be an effective target for developing medicines that treat type 2 diabetes mellitus (T2DM). GLP-1R agonists improve T2DM by enhancing glucose-stimulated insulin secretion...
Salvato in:
| Pubblicato in: | ACS Pharmacol Transl Sci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American
Chemical Society
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7088942/ https://ncbi.nlm.nih.gov/pubmed/32219200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.8b00009 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|